Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2003
08/20/2003EP1335915A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/20/2003EP1335905A1 Hetero-anellated ortho-aminophenols and their use as dye components
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335730A1 Treatment of premature ejaculation
08/20/2003EP1254139B1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
08/20/2003EP1173520B1 Novel amidopyrylium fluorescence dyes
08/20/2003EP1173519B1 Novel carbopyronine fluorescence dyes
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003EP0734724B1 Process for the preparation of a phencynonate hydrochloride of alpha-configuration
08/20/2003CN1437600A Pyrroloquinolones as antiviral agents
08/20/2003CN1437597A Substituted phenyl-Piperazine derivatives, their preparation and use
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1436782A Pyridine compounds and their prepn and application as Dopamine D4 receptor agonist
08/20/2003CN1118467C 1,3,8-triaza-spiro [4,5] decan-4-on derivatives
08/20/2003CN1118460C Pyrimidine derivatives as 5HT2C-receptor antagonists
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/19/2003US6608201 Amidation of a 2-halo-3,4-diaminoquinoline with an acid chloride; dehalogenation, amination with ammonia; cyclization
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608193 Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
08/19/2003US6608086 Dihydropyridines and new uses thereof
08/19/2003US6608081 Treating pneumonia
08/19/2003US6608080 Morphan derivatives or salts thereof and medicinal compositions containing the same
08/19/2003US6608076 Treating topoisomerase I inhibitor-related disease in mammals
08/19/2003US6608072 Inhibiting production of soluble tumor necrosis factor or reducing inflammation
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608065 Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction
08/19/2003US6608064 Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas
08/19/2003US6608060 Treating inflammatory diseases, destructive bone disorders, reperfusion/ischemia in stroke, myocardial ischemia, renal ischemia, cardiac hypertrophy, rheumatoid arthritis, inflammatory bowel disease, or Crohn's disease
08/19/2003US6608056 Phosphatidylinositol 3-kinase inhibitors and carcinostatic agents
08/19/2003US6608053 Phosphatidylinositol 3-kinase (PI3K) inhibitors/anticancer agents such as N-(2-(3-benzenesulfonylaminophenyl)-4-morphoniloquinazolin-6-yl)acetamide
08/19/2003US6607890 Mismatch-recognizing molecules
08/19/2003CA2088454C Diazabicyclo derivatives
08/19/2003CA2085620C Mono(indolylethylenyl)phthalides
08/14/2003WO2003067286A2 Nanofilm and membrane compositions
08/14/2003WO2003066646A2 Macrocyclic module compositions
08/14/2003WO2003066634A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003WO2003066632A1 Sulphonyl compounds with 5 -ht6 receptor affinity
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066624A1 Pyrimidinonesulfamoylureas as integrin ligands
08/14/2003WO2003066622A1 Novel benzimidazole compounds
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066592A1 Gamma secretase inhibitors
08/14/2003WO2003066586A2 Purine and isosteric antibacterial compounds
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066099A1 2,4,6-triamino-1,3,5-triazine derivative
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003053941A3 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153762 Process for preparing imidazoquinolinamines
08/14/2003US20030153759 1-Glyoxlylamide indolizines for treating cancer
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153595 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
08/14/2003US20030153586 7-oxo-pyridopyrimidines (I)
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153574 Such as 4-(Benzoxazol-2-yl)-1,4-diazabicyclo(3.2.2)nonane hydrobromide which stimulates nicotinic receptors
08/14/2003US20030153572 Compounds and methods for the treatment of pain
08/14/2003US20030153571 Such as 7-Chloro-4-hydroxy-2-(3-pyridyleth-1-yl)-1,2,5,10-tetrahydropyridazino(4,5, -b)quinoline-1,10-dione methanesulfonate, which binds NMDA receptors (N-methyl-aspartic acid receptors); neuropathy
08/14/2003US20030153565 Prevention or treatment of gastrointestinal diseases
08/14/2003US20030153563 CRF receptor antagonists and methods relating thereto
08/14/2003US20030153561 Pyrroloquinolones as antiviral agents
08/14/2003US20030153558 Immunomodulators and/or inhibiting cytokine release
08/14/2003US20030153552 Method of treating chemical dependency in mammals and a composition therefor
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153005 Naphthalenebisimide compound
08/14/2003CA2486446A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003CA2478423A1 Gamma secretase inhibitors
08/14/2003CA2475646A1 Macrocyclic module compositions
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475567A1 Nanofilm and membrane compositions
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2473724A1 Purine and isosteric antibacterial compounds
08/13/2003EP1334972A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH)
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1334092A1 Process for preparation of bicyclic and polycyclic molecules
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
08/13/2003EP1216244B1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists
08/13/2003EP0945435B1 Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
08/13/2003EP0885888B1 Isoquinoline derivatives and drugs
08/13/2003EP0808313B1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/13/2003EP0751774B1 Hypocholesterolemic mercaptoacetylamide disulfide derivatives
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436191A Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
08/13/2003CN1436189A Non-nucleoside reverse transcriptase inhibitors
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436079A Imidazopyridine and imidazopyrimidine antiviral agent
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605720 Process for making spirolactone compounds
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605630 Active against drug resistant gram positive pathogens
1 ... 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 ... 646